Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma

BACKGROUND: Circulating cytokines and angiogenic factors have been associated with clinical outcomes in patients with metastatic renal cell carcinoma (RCC) receiving systemic therapy. However, none have yet examined cytokine concentrations in parallel cohorts receiving either immunotherapy or target...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehrazi-Raffle, Alexander, Meza, Luis, Alcantara, Marice, Dizman, Nazli, Bergerot, Paulo, Salgia, Nicholas, Hsu, JoAnn, Ruel, Nora, Salgia, Sabrina, Malhotra, Jasnoor, Karczewska, Ewa, Kortylewski, Marcin, Pal, Sumanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944971/
https://www.ncbi.nlm.nih.gov/pubmed/33688021
http://dx.doi.org/10.1136/jitc-2020-002009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944971/
https://www.ncbi.nlm.nih.gov/pubmed/33688021
http://dx.doi.org/10.1136/jitc-2020-002009

Ejemplares similares